Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Smoking Cessation 11Tobacco Use Disorder 6Lung Neoplasms 5Uterine Cervical Neoplasms 4Tobacco Use Cessation 4Smoking 4Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Tobacco Use 2Tobacco Smoking 2Small Cell Lung Carcinoma 2Neoplasms 2Head and Neck Neoplasms 2Cigarette Smoking 2Acquired Immunodeficiency Syndrome 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Substance-Related Disorders 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1

Interventions

Vincristine 1VGX-3100 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Rituximab 1Prednisone 1Etoposide 1Electroporation Therapies 1Electroporation 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × HIV Seropositivity × Tobacco Use Cessation Devices × Clear all
NCT02302859 2020-01-27

Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot Study

M.D. Anderson Cancer Center

Phase NA Terminated
8 enrolled 3 charts

Acquired Immunodeficiency Syndrome, HIV Seropositivity, Tobacco Use Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡